Margaret Dixon competitive analysis

Explore patent oppositions filed by Margaret Dixon against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Methods For Purification Of Messenger RnaTRANSLATE BIOAug 4, 2026
Polyol-Modified Lipid Compound And Preparation Method And Application ThereofJENKEM TECHNOLOGYJul 13, 2026
Method For Producing Cd8Alpha+Beta+Cytotoxic T CellsKYOTO UNIVERSITYJul 6, 2026
Synergistic Enhancement Of The Delivery Of Nucleic Acids Via Blended FormulationsTRANSLATE BIOFeb 19, 2026
A Myostatin Pathway Inhibitor In Combination With A Glp-1 Pathway Activator For Use In Treating Metabolic DisordersSCHOLAR ROCKDec 3, 2025
Method For Generating T-Cells Compatible For Allogenic TransplantationCELLECTISSep 30, 2025
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 16, 2025
Artificial Lash ExtensionsLASHIFYJun 4, 2025
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESMay 21, 2025
Charged Depth Filtration Of Antigen-Binding ProteinsAMGENMay 7, 2025

Latest PTAB cases involving Margaret Dixon

Discover the latest PTAB cases involving Margaret Dixon, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Margaret Dixon with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MARGARET DIXON65 - - -
GLAXOSMITHKLINE BIOLOGICALS SA149329
GUARDANT HEALTH - 321416
NOVARTIS6467 - 21